RecallRadar

FDA Device recall Z-1519-2025

t:slim X2 Insulin Pump with Interoperable Technology

On 2025-04-23 the FDA classified a Class I recall of t:slim X2 Insulin Pump with Interoperable Technology by Tandem Diabetes Care, citing A software defect in Version 7.9 of the pump software for Tandem t:slim X2 and Tandem Mobi pumps, when used with Control IQ+ technology, will cause the pump to incorrectly interpo….

Read the official FDA Device notice

AgencyFDA Device
Recall numberZ-1519-2025
ClassificationClass I
Statusongoing
Initiated2025-02-27
Published2025-04-23
Last updated2026-09-13 11:57 UTC
CompanyTandem Diabetes Care
DistributionAZ, CA, CO, CT, FL, HI, IA, ID, IL, IN, MD, ME, MI, MO, MS, NC, ND, NE, NJ, NM, NV, NY, OH, PA, TX, UT, VA, WA, WI

Product

t:slim X2 Insulin Pump with Interoperable Technology

Reason

A software defect in Version 7.9 of the pump software for Tandem t:slim X2 and Tandem Mobi pumps, when used with Control IQ+ technology, will cause the pump to incorrectly interpolate glucose trends when the Estimated Glucose Value (EGV) is above 255 mg/dL at the start or end of a gap in data collection due to a lapse in connection from a paired continuous glucose monitor (CGM) sensor, which can lead to under-delivery or over-delivery of insulin based on inaccurate result leading to severe cases of hypoglycemia or hyperglycemia.

Identifiers

code_infoSoftware versions 7.9/UDI: 00389152407012

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:57 UTC. Current status: ongoing.

Source

Official record: https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-1519-2025%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.